Bioelectronics Corp (BIEL)

[Daytime_Lantern]

As shareholders, why don't we demand that BIEL provides a detailed account regarding the FDA's stated reason(s) for the clearance denial. Start by giving us the delineated trial numbers associated with the (Not Good Enough Men's data), and the apparent (Acceptable Women's Numbers). Furthermore, if the female numbers were apparently good enough, then why won't BIEL resubmit with a female bias. It's reasonable to think that this could be done in very short order, since the trial metrics remain in BIEL's possession, so why not do this? There are a lot of questions which need to be answered. At least, acceptable answers might provide some degree of closure to this highly disappointing situation.

GLTA!!!